該雜志國際簡稱:PLOS MED,是由出版商Public Library of Science出版的一本致力于發(fā)布醫(yī)學研究新成果的的專業(yè)學術期刊。該雜志以MEDICINE, GENERAL & INTERNAL研究為重點,主要發(fā)表刊登有創(chuàng)見的學術論文文章、行業(yè)最新科研成果,扼要報道階段性研究成果和重要研究工作的最新進展,選載對學科發(fā)展起指導作用的綜述與專論,促進學術發(fā)展,為廣大讀者服務。該刊是一本國際優(yōu)秀雜志,在國際上有很高的學術影響力。
《Plos Medicine》是一本以English為主的開放獲取國際優(yōu)秀期刊,中文名稱普洛斯醫(yī)學,本刊主要出版、報道醫(yī)學-MEDICINE, GENERAL & INTERNAL領域的研究動態(tài)以及在該領域取得的各方面的經(jīng)驗和科研成果,介紹該領域有關本專業(yè)的最新進展,探討行業(yè)發(fā)展的思路和方法,以促進學術信息交流,提高行業(yè)發(fā)展。該刊已被國際權威數(shù)據(jù)庫SCIE收錄,為該領域相關學科的發(fā)展起到了良好的推動作用,也得到了本專業(yè)人員的廣泛認可。該刊最新影響因子為10.5,最新CiteScore 指數(shù)為21.6。
本刊近期中國學者發(fā)表的論文主要有:
Age-specific population attributable risk factors for all-cause and cause-specific mortality in type 2 diabetes: An analysis of a 6-year prospective cohort study of over 360,000 people in Hong Kong
Author: Wu, Hongjiang; Lau, Eric S. H.; Yang, Aimin; Zhang, Xinge; Fan, Baoqi; Ma, Ronald C. W.; Kong, Alice P. S.; Chow, Elaine; So, Wing-Yee; Chan, Juliana C. N.; Luk, Andrea O. Y.
The cost and cost-effectiveness of novel tuberculosis vaccines in low- and middle-income countries: A modeling study
Author: Portnoy, Allison; Clark, Rebecca A.; Quaife, Matthew K.; Weerasuriya, Chathika K.; Mukandavire, Christinah; Bakker, Roel; Deol, Arminder K.; Malhotra, Shelly; Gebreselassie, Nebiat; Zignol, Matteo; Sim, So Yoon; Hutubessy, Raymond C. W. G.; Baena, Ines Garcia A.; Nishikiori, Nobuyuki; Jit, Mark; White, Richard G.; Menzies, Nicolas A.
Improving cascade outcomes for active TB: A global systematic review and meta-analysis of TB interventions
An influential venue for research and commentary on the major challenges to human health worldwide, PLOS Medicine publishes articles of general interest on biomedical, environmental, social and political determinants of health. The journal emphasizes work that advances clinical practice, health policy or pathophysiological understanding to benefit health in a variety of settings.
該雜志是一本國際頂級雜志,在醫(yī)學-MEDICINE, GENERAL & INTERNAL學科領域中屬于核心刊物,是能夠綜合反映該學科領域當前最高發(fā)展水平的學術期刊。在國際上有很高的學術影響力,行業(yè)關注度很高,已被國際權威數(shù)據(jù)庫SCIE收錄,該雜志在MEDICINE, GENERAL & INTERNAL綜合專業(yè)領域專業(yè)度認可很高,對稿件內容的創(chuàng)新性和學術性要求非常高,作為一本國際頂級雜志,一般投稿過審時間都較長,投稿過審時間平均 偏慢,4-8周 ,如果想投稿該刊要做好時間安排。版面費不祥。該雜志近兩年未被列入預警名單,建議您投稿。如您想了解更多投稿政策及投稿方案,請咨詢客服。